WeVote
Log In

Bill

Bill

GM 1207

Informing the Legislature that on May 29, 2025, the Governor signed the following bill into law: SB1452 SD1 HD2 CD1 (ACT 107).

2025 Regular Session

Act 107 updates Hawaii's controlled substances law by adding new opiates, enhancing regulations to combat substance abuse, impacting healthcare and law enforcement practices.

Received.
#act107
0
WeVote Research Nonpartisan
Bill Summary · GM 1207

Summary of GM 1207 - Proclamation of Act 107

Bill Information

  • Bill Number: GM 1207
  • Title: Informing the Legislature that on May 29, 2025, the Governor signed the following bill into law: SB1452 SD1 HD2 CD1 (ACT 107).
  • Status: Received
  • Introduced: May 29, 2025
  • Classification: Proclamation
  • Subject: Act 107

Purpose and Intent

GM 1207 serves as a formal proclamation from Governor Josh Green, M.D., notifying the Hawaii State Legislature that Senate Bill 1452, which relates to the Uniform Controlled Substance Act, has been signed into law as Act 107. The intent of this legislation is to amend existing laws regarding controlled substances, specifically focusing on the regulation of various opiates.

Key Provisions

The primary amendment made by Act 107 involves the modification of Section 329-14 of the Hawaii Revised Statutes, which governs the classification of controlled substances. The bill includes the following key changes:

  • Addition of New Opiates: The bill lists several new opiates that are now classified as controlled substances. This includes, but is not limited to:

    • Acetyl-alpha-methylfentanyl
    • Acetylmethadol
    • Fentanyl derivatives such as Acryl fentanyl, Alpha-methylfentanyl, and others.

  • Comprehensive Listing: The amendment provides a detailed list of opiates, including their isomers, esters, and salts, ensuring that all variations of these substances are regulated under the law.

  • Regulatory Framework: By updating the list of controlled substances, the bill aims to enhance the regulatory framework surrounding the use and distribution of potent opiates, thereby addressing public health concerns related to substance abuse.

Affected Parties

The enactment of Act 107 will impact:
- Healthcare Providers: Physicians and pharmacists will need to adjust their practices to comply with the updated classifications of controlled substances.
- Law Enforcement: Agencies will have updated guidelines for the enforcement of drug-related laws.
- Patients: Individuals prescribed these substances may experience changes in availability and prescription practices.

Procedural Aspects

  • Date of Signing: The bill was signed into law by the Governor on May 29, 2025.
  • Legislative Action: The proclamation was officially received by the legislature on the same date, indicating prompt communication of the law's enactment.

Conclusion

GM 1207 is a significant legislative action that updates Hawaii's approach to controlling opiate substances. By formally notifying the legislature of the signing of Act 107, the bill underscores the state's commitment to addressing the challenges posed by substance abuse and ensuring public safety through effective regulation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.